Satter Muneer A 13D and 13G filings for Aileron Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2021-01-08 4:04 pm Purchase | 2021-01-06 | 13D | Aileron Therapeutics, Inc. ALRN | Satter Muneer A | 1,017,040 19.900% | 450,000 (+79.36%) | Filing |
| 2020-06-09 5:13 pm Purchase | 2020-06-08 | 13D | Aileron Therapeutics, Inc. ALRN | Satter Muneer A | 567,040 19.900% | 185,000 (+48.42%) | Filing |